Thomas J. Schuetz
2022
In 2022, Thomas J. Schuetz earned a total compensation of $2.1M as President of Research & Development formerly CEO at Compass Therapeutics, a 60% decrease compared to previous year.
Compensation breakdown
| Bonus | $275,000 |
|---|---|
| Option Awards | $1,285,628 |
| Salary | $550,000 |
| Other | $4,557 |
| Total | $2,115,185 |
Schuetz received $1.3M in option awards, accounting for 61% of the total pay in 2022.
Schuetz also received $275K in bonus, $550K in salary and $4.6K in other compensation.
Rankings
In 2022, Thomas J. Schuetz's compensation ranked 1,684th out of 5,760 executives tracked by ExecPay. In other words, Schuetz earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,684 out of 5,760 | 71st |
Division Manufacturing | 878 out of 3,136 | 72nd |
Major group Chemicals And Allied Products | 351 out of 1,422 | 75th |
Industry group Drugs | 324 out of 1,323 | 76th |
Industry Biological Products, Except Diagnostic Substances | 80 out of 291 | 73rd |
Source: SEC filing on April 29, 2024.
Schuetz's colleagues
We found one more compensation record of an executive who worked with Thomas J. Schuetz at Compass Therapeutics in 2022.
2022
Vered Bisker-Leib
Compass Therapeutics